TY - JOUR
T1 - Paraneoplastic cerebellar degeneration in ovarian carcinoma
T2 - Case report with review of immune modulation
AU - Bradley, W. H.
AU - Dottino, P. R.
AU - Rahaman, J.
PY - 2008/11
Y1 - 2008/11
N2 - Paraneoplastic cerebellar degeneration (PCD) is a rare nonmetastatic complication of a carcinoma. It is typically mediated by antibodies generated against tumor antigens. These antigens are the same proteins as expressed on Purkinje cells within the cerebellum; immune activation in the central nervous system (CNS) results in the syndrome. A 56-year-old woman with stage IIIC serous ovarian carcinoma diagnosed 3 years prior developed progressive limb ataxia. Serum anti-Yo antibodies were positive, confirming the diagnosis of PCD. Treatment with plasmaphoresis, intravenous immune globulin, and immune modulation with corticosteroids and tacrolimus was unsuccessful. Although the syndrome can be debilitating and treatment options are limited, it may also be an example of a successful host immune response in certain cases.
AB - Paraneoplastic cerebellar degeneration (PCD) is a rare nonmetastatic complication of a carcinoma. It is typically mediated by antibodies generated against tumor antigens. These antigens are the same proteins as expressed on Purkinje cells within the cerebellum; immune activation in the central nervous system (CNS) results in the syndrome. A 56-year-old woman with stage IIIC serous ovarian carcinoma diagnosed 3 years prior developed progressive limb ataxia. Serum anti-Yo antibodies were positive, confirming the diagnosis of PCD. Treatment with plasmaphoresis, intravenous immune globulin, and immune modulation with corticosteroids and tacrolimus was unsuccessful. Although the syndrome can be debilitating and treatment options are limited, it may also be an example of a successful host immune response in certain cases.
KW - Cerebellar degeneration
KW - Ovarian cancer
KW - Paraneoplastic syndrome
UR - https://www.scopus.com/pages/publications/40749152616
U2 - 10.1111/j.1525-1438.2007.01173.x
DO - 10.1111/j.1525-1438.2007.01173.x
M3 - Article
C2 - 18217973
AN - SCOPUS:40749152616
SN - 1048-891X
VL - 18
SP - 1364
EP - 1367
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
IS - 6
ER -